🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

4 recruiting trials

for Multiple System Atrophy - Parkinsonian Subtype (MSA-P)

The Study of Safety and Preliminary Efficacy of Aleeto in Patients With MultIple System Atrophy NCT06765733EARLY Phase 11 site📍 Beijing Beijing Tiantan Hospital · Tests: Aleeto The CurePSP Genetics Program NCT06647641n/a1 site📍 Boston Massachusetts General Hospital · Tests: Whole genome sequencing will be performed at the NIH Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease NCT06920134NA1 site📍 Lausanne Ecole Polytechnique Fédérale de Lausanne · Tests: ARC-IM Investigational System A Phase I/III Clinical Study to Evaluate NouvNeu001 Injection for Multiple System Atrophy NCT07289477Phase 11 site📍 Beijing iRegene Therapeutics Co., Ltd. · Tests: Human Dopaminergic Progenitor Cells
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy